drugset / Trial / NCT05167760

Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis

NCT05167760

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine efficacy of apraclonidine for patients with ocular synkinesis, who are seen in the UAB Facial Nerve Clinic.

Timeline

Start
2025-12
Primary completion
2027-11
Completion
2028-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Apraclonidine Small molecule 1 unknown Topical
Subject Apraclonidine Small molecule 2 unknown Topical